Association of Treatment With 5α-Reductase Inhibitors and Prostate Cancer Mortality Among Older Adults.
prospective_cohort · Level II
Where this comes from
- Record sourced from PubMed, PMID 31626312.
- Also identified by DOI 10.1001/jamanetworkopen.2019.13612 and PMC identifier 6813580.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
This cohort study examines the association between use of 5α-reductase inhibitors and prostate cancer mortality among US Medicare beneficiaries.
Medical subject headings
- 5-alpha Reductase Inhibitors
- Prostate-Specific Antigen
- Prostatic Neoplasms